BrainsWay is proud to participate in the 2025 American Psychiatric Association Annual Meeting in Los Angeles, where the company will host live Deep TMS demonstrations at its exhibit booth and join a high-profile Master Course exploring cutting-edge treatments in psychiatry. BrainsWay’s Chief Medical Officer, Dr. Richard Bermudes, and VP of Medical Affairs, Dr. Colleen Hanlon, will present on the clinical applications of TMS, reinforcing the company’s leadership in mental health innovation. Click below to learn more about our role at APA 2025 and how Deep TMS is shaping the future of psychiatric care.
https://www.globenewswire.com/news-release/2025/05/01/3072312/17676/en/BrainsWay-to-Showcase-Deep-TMS-at-the-2025-American-Psychiatric-Association-Annual-Meeting-in-Los-Angeles.html
